Company overview
Endometrics develops non-invasive diagnostic tests for endometriosis and women's health conditions using menstrual blood as an organ-proximal liquid biopsy. The company integrates tissue-derived biomarker discovery, proprietary bioinformatics, and at-home sampling for scalable molecular diagnostics of gynecologic diseases. Endometrics won first prize in the NIH RADx Tech ACT ENDO Challenge for its clinically graded test collected at home.
Endometrics is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include endometriosis diagnostics, menstrual blood test, non-invasive diagnostics, women's health, molecular diagnostics.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Endometrics include Diagnostic — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://endometrics.us
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- endometriosis diagnostics, menstrual blood test, non-invasive diagnostics, women's health, molecular diagnostics
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What diagnostic tests does Endometrics offer?
- Endometrics offers a non-invasive diagnostic test for endometriosis using menstrual blood analysis, featuring proprietary biomarkers and at-home collection for clinical grading.
- What are Endometrics' key capabilities in women's health?
- The company specializes in molecular diagnostics for gynecologic diseases, combining biomarker discovery, bioinformatics, and scalable at-home sampling from menstrual blood.
- Has Endometrics received regulatory or innovation recognition?
- Endometrics won first prize in the NIH RADx Tech ACT ENDO Challenge, recognizing its progress in developing novel non-invasive endometriosis diagnostics.
Related editorial coverage
- The Perimenopause Movement: A Double-Edged Sword for Women
- FDA Approves Veozah: New Non-Hormonal Menopause Treatment
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
Explore lab tools and QA/QC resources for R&D teams.
